<?xml version="1.0" encoding="UTF-8"?>
<p>Remdesivir (GS-5734) has been developed by Gilead Sciences, Inc. It acts as a prodrug of adenosine analogue, inhibiting RNA-dependent RNA polymerase (RdRp) enzyme. Additionally, it also seems to block the viral genome replication process.</p>
